Cytosurge AG

Subcategories

FluidFM® BOT BIO Series

Advance your single cell research

Cytosurge AG is an ETH Zurich spin-off Company based in Zurich, Switzerland. The vision of Cytosurge is to provide a new generation of tools to stimulate novel applications at the forefront of nanotechnology, life sciences and single cell biology.

The company develops the patented FluidFM technology and is present in all major markets throughout Europe, Asia and the Americas. Cytosurge AG is a passionate team of specialists with backgrounds in various disciplines from business, engineering, biology and computer science

Attachment	Size
Cytosurge Brochure	2.45 MB

Last News

28/07/2020

What are the big challenges researchers are facing in single cell analysis?

24/07/2020

Digital FluidFM User Conference 2020

06/03/2020

Webinar Thu, Mar 19, 2020 2:00 PM - 3:00 PM CET - FluidFM: a new approach to CRISPR gene editing

Products List

Single Cell Manipulation - FluidFM®

FluidFM SPECTRA

FluidFM SPECTRA - Cytosurge AG

A unique system for research facilities, specifically designed to exploit the versatility of FluidFM technology to the fullest

FluidFM QUANT SYSTEM

FluidFM QUANT - Cytosurge AG

Deliver any drug into a cell, quantify the dose and study its effects at single cell level

FluidFM BOT CRISPR

FluidFM BOT CRISPR - Cytosurge AG

Deliver your CRISPR-Cas complexes directly to where they are needed: the nucleus

FluidFM® PROBES

FluidFM micropipettes

FluidFM micropipettes - Cytosurge

FluidFM nanopipette

FluidFM nanopipette - Cytosurge

FluidFM nanosyringe

FluidFM nanosyringe - Cytosurge probes

FluidFM nano-injection into single cells.